Drug Discovery World

AUGUST 9, 2022

This technology enables the expression of human drug-metabolizing enzymes in bacteria, without requiring large modifications to the proteins.? . Cypex’s product portfolio contains more than 115 recombinant enzymes, including CYPs, UGTs, CES, and AOX, and companion chemicals and media.

In-Vitro 52

In-Vitro Protein Production Bacteria 52

Drug Discovery World

SEPTEMBER 28, 2023

This is likely in part because their byproduct, lactic acid, is known to inhibit pathogenic bacteria 25. And, in the endometrium, a decrease in Lactobacillus may affect embryo attachment and promote the growth of detrimental bacteria. This article will focus on one such area of great unmet need and promise: women’s health.

Clinical Trials 65

Clinical Trials Clinical Trials Regulation Bacteria 65

XTalks

AUGUST 9, 2023

Xdemvy, specifically formulated as an ectoparasiticide (anti-parasitic) for Demodex blepharitis treatment, contains the active ingredient lotilaner, a member of the isoxazoline compound family. California-based Tarsus Pharmaceuticals Inc., Xdemvy is now authorized to treat Demodex blepharitis, offering a new option for affected patients.

FDA Approval 98

FDA Approval In-Vitro Trials Bacteria 98

The Pharma Data

APRIL 28, 2021

Fosmanogepix has demonstrated broad-spectrum activity in-vitro and has shown wide distribution to various tissues including the brain, lung, kidney and eye. Infections are caused by different types of pathogens, including bacteria, viruses, fungi and parasites, and can be acquired in the community or in a hospital or healthcare setting.

Clinical Trials 40

Clinical Trials Clinical Trials Containment In-Vitro 40

The Pharma Data

OCTOBER 22, 2020

Sulopenem has demonstrated potent in vitro activity against a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. This press release contains forward-looking statements. DUBLIN, Ireland and CHICAGO, Oct. per ordinary share (or pre-funded warrant) and associated warrant.

In-Vitro 40

In-Vitro Clinical Trials Clinical Trials Sales 40

Roots Analysis

OCTOBER 16, 2023

These clones can be manipulated and mutated in vitro to alter the expression and function of a protein. These clones can be manipulated and mutated in vitro to alter the expression and function of a protein. There are some motifs, such as hairpin loops which hinder the usability of a gene.

DNA 40

DNA Gene Protein In-Vitro 40

Drug Discovery World

DECEMBER 29, 2023

Given their role in regulating cellular functions, it comes as no surprise that membrane proteins are the primary targets for the majority of currently marketed therapeutics. Consequently, the selection and optimisation of membrane mimetics is one of the main bottlenecks in structural and functional studies of membrane proteins.

Protein 52

Protein In-Vitro Research Drugs 52